Your browser doesn't support javascript.
loading
Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients.
Nylund, S J; Ruutu, T; Saarinen, U; Larramendy, M L; Knuutila, S.
Affiliation
  • Nylund SJ; Department of Medical Genetics, University of Helsinki, Finland.
Leukemia ; 8(4): 587-94, 1994 Apr.
Article in En | MEDLINE | ID: mdl-8152255
Subject(s)
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid / Chromosome Aberrations / In Situ Hybridization, Fluorescence / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1994 Type: Article Affiliation country: Finland
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid / Chromosome Aberrations / In Situ Hybridization, Fluorescence / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1994 Type: Article Affiliation country: Finland